Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04062955 · ClinicalTrials.gov registry record · NA

Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants

A NA study of Healthy Subject, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT04062955: Completed NA study of Healthy Subject, sponsored by Fred Hutchinson Cancer Center.

NCT04062955 is a NA study of Healthy Subject that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 21 participants, below the 247-participant average among 16 other Healthy Subject trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04062955, a NA study of Healthy Subject, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

This trial studies the effects of a dietary intervention based on the Alternative Healthy Eating Index (AHEI) on inflammatory markers and breast density in healthy participants. The AHEI is a quantifiable measure of diet quality designed to target food and macronutrient sources that are associated with chronic disease risk. Adherence to the AHEI may be associated with a reduction in inflammatory biomarkers and sex steroid hormone levels compared to other dietary patterns/scores.

Primary Outcome

Levels of IL-6, IL-1β, sTNFR-1, and sTNFR-2 will be measured by immunoassay. hsCRP levels will be measured using a high-sensitivity latex-enhanced immunonephelometric assay on a BNII analyzer.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • DIETARY_SUPPLEMENT Dietary Intervention
  • PROCEDURE Dual X-ray Absorptiometry

Study Locations (1)

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2019-10-28
Est. Completion 2020-11-19
Phase NA
Fred Hutchinson Cancer Center

483 total trials

What the finished NCT04062955 record still lists

NCT04062955 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 247-participant average among 16 other Healthy Subject trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Healthy Subject appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT04062955 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT04062955 about?

NCT04062955 is a clinical study titled "Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants". This trial studies the effects of a dietary intervention based on the Alternative Healthy Eating Index (AHEI) on inflammatory markers and breast density in healthy participants. The AHEI is a quantifiable measure of diet quality designed to target food and macronutrient sources that are associated w...

What is the current status of trial NCT04062955?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-10-28. Estimated completion is 2020-11-19.

What conditions does trial NCT04062955 study?

This clinical trial studies the following conditions: Healthy Subject.

What interventions are being tested in trial NCT04062955?

The interventions under investigation include: Questionnaire Administration (OTHER), Dietary Intervention (DIETARY_SUPPLEMENT), Dual X-ray Absorptiometry (PROCEDURE).

Who is sponsoring clinical trial NCT04062955?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04062955 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subject

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04062955's enrollment target sits among peer trials

21 15th of 16 higher than 2 of 16 other Healthy Subject trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Subject trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04062955, the US trial registry maintained by the National Library of Medicine. NCT04062955 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.